JP2020524132A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020524132A5 JP2020524132A5 JP2019565526A JP2019565526A JP2020524132A5 JP 2020524132 A5 JP2020524132 A5 JP 2020524132A5 JP 2019565526 A JP2019565526 A JP 2019565526A JP 2019565526 A JP2019565526 A JP 2019565526A JP 2020524132 A5 JP2020524132 A5 JP 2020524132A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- amino acid
- therapeutic
- replaced
- acid residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762515272P | 2017-06-05 | 2017-06-05 | |
| US62/515,272 | 2017-06-05 | ||
| PCT/US2018/036116 WO2018226735A1 (en) | 2017-06-05 | 2018-06-05 | Compositions and methods for treating alzheimer's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020524132A JP2020524132A (ja) | 2020-08-13 |
| JP2020524132A5 true JP2020524132A5 (enExample) | 2020-09-24 |
Family
ID=64567326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565526A Pending JP2020524132A (ja) | 2017-06-05 | 2018-06-05 | アルツハイマー病を治療するための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200093890A1 (enExample) |
| EP (1) | EP3634979A4 (enExample) |
| JP (1) | JP2020524132A (enExample) |
| KR (1) | KR20200045446A (enExample) |
| CN (1) | CN110945011A (enExample) |
| AU (1) | AU2018281330A1 (enExample) |
| CA (1) | CA3064479A1 (enExample) |
| WO (1) | WO2018226735A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024253848A1 (en) * | 2023-04-03 | 2025-10-30 | Nervgen Pharma Corp. | Protein tyrosine phosphatase wedge domain peptide dimer for nervous system repair |
| WO2025092748A1 (zh) * | 2023-11-01 | 2025-05-08 | 拜西欧斯（北京）生物技术有限公司 | 多肽衍生物、其药物组合物及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002308460A1 (en) * | 2001-04-12 | 2002-10-28 | Mcgill University | The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification |
| US7829087B2 (en) * | 2001-07-09 | 2010-11-09 | Elan Pharmaceuticals, Inc. | Methods of treating cognitive impairment |
| WO2008157425A2 (en) * | 2007-06-14 | 2008-12-24 | The Regents Of The University Of California | Compounds for inhibiting protein aggregation, and methods for making and using them |
| JP5944822B2 (ja) * | 2009-06-15 | 2016-07-05 | フエー・イー・ベー・フエー・ゼツト・ウエー | Ｂａｃｅ１抑制性抗体 |
| WO2012019086A2 (en) * | 2010-08-06 | 2012-02-09 | The University Of North Carolina At Chapel Hill | Inhibition of lar phosphatase to enhance therapeutic angiogenesis |
| CN106902108B (zh) * | 2012-03-19 | 2020-07-21 | 巴克老龄化研究所 | App特异性bace抑制剂(asbi)及其用途 |
| JP6268164B2 (ja) * | 2012-04-09 | 2018-01-24 | ケース ウエスタン リザーブ ユニバーシティ | Ｌａｒファミリーホスファターゼの活性を阻害する組成物及び方法 |
| CN109414482A (zh) * | 2016-05-12 | 2019-03-01 | 俄亥俄州创新基金会 | 用于治疗神经退行性疾病的肽和方法 |
-
2018
- 2018-06-05 CA CA3064479A patent/CA3064479A1/en active Pending
- 2018-06-05 AU AU2018281330A patent/AU2018281330A1/en not_active Abandoned
- 2018-06-05 JP JP2019565526A patent/JP2020524132A/ja active Pending
- 2018-06-05 WO PCT/US2018/036116 patent/WO2018226735A1/en not_active Ceased
- 2018-06-05 US US16/619,317 patent/US20200093890A1/en active Pending
- 2018-06-05 KR KR1020197037319A patent/KR20200045446A/ko not_active Ceased
- 2018-06-05 EP EP18813399.5A patent/EP3634979A4/en not_active Withdrawn
- 2018-06-05 CN CN201880036972.2A patent/CN110945011A/zh active Pending